Wavemaker Three Sixty Health

Venture Capital & Private Equity, 301 N Lk Ave, Pasadena, California, United States, 11-50 Employees

wavemaker360.com

  • twitter
  • LinkedIn

Who is WAVEMAKER THREE-SIXTY HEALTH

Wavemaker Three-Sixty Health is the leading U.S. seed stage venture capital fund focused 100% on healthcare. The fund is backed almost exclusively by healthcare LPs - both leading organiz...

Read More

map
  • 301 N Lk Ave, Pasadena, California, United States Headquarters: 301 N Lk Ave, Pasadena, California, United States
  • 2018 Date Founded: 2018
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

checked-icon Does something look wrong? Fix it. | View contact records from WAVEMAKER THREE-SIXTY HEALTH

Wavemaker Three-Sixty Health Org Chart and Mapping

Employees

Similar Companies to Wavemaker Three-Sixty Health

Red Cell Partners

  • 51-200 51-200
  • 5 Million to 10 Million $ 5 Million to 10 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Wavemaker Three-Sixty Health

Answer: Wavemaker Three-Sixty Health's headquarters are located at 301 N Lk Ave, Pasadena, California, United States

Answer: Wavemaker Three-Sixty Health's official website is https://wavemaker360.com

Answer: Wavemaker Three-Sixty Health's revenue is $1 Million to $5 Million

Answer: Wavemaker Three-Sixty Health has 11-50 employees

Answer: Wavemaker Three-Sixty Health is in Venture Capital & Private Equity

Answer: Wavemaker Three-Sixty Health top competitors include: Red Cell Partners

Answer: Wavemaker Three-Sixty Health contact info: Phone number: Website: https://wavemaker360.com

Answer: Wavemaker Three-Sixty Health is the leading U.S. seed stage venture capital fund focused 100% on healthcare. The fund is backed almost exclusively by healthcare LPs - both leading organizations and prominent individual executives - across payers, providers (across the continuum of care), and pharma. This gives the fund a unique advantage with respect to identifying, evaluating and most importantly supporting early-stage healthcare technology companies.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access